A listed fintech company that simplifies back office functions for accountants and financial advisers doesn’t exactly have the same investor ‘sex appeal’ as neo banks, bitcoin players or the buy-now-pay-later sector. But that doesn’t mean it won’t generate exciting returns for investors. A giant in the self managed super funds (SMSF) administration sector, Class Limited
Read More
Working in conjunction with the CSIRO, Anatara Lifesciences (ASX: ANR) has received ethics approval to apply their diet supplement 3FDC to a new area of medicine, seeking to evaluate the compound’s effects in adults with moderate anxiety, stress and depression. 3FDC is one of the constituents of Anatara’s flagship supplement (GaRP) intended for the treatment
Read More
Having realised the incredible savings made from the mass-adoption of self-service checkouts, Woolworths (ASX: WOW) could soon have an array of other automation-driven initiatives having secured the controlling interest of data science company Quantium for $223 million. The investment will increase Woolworth’s existing shareholding from 47% to 75% following a hugely successful partnership where Quantium’s
Read More
Sensing the commercial appeal of soccer’s European Super League, some of the world’s largest multinational corporations are set to announce their involvement in the European Super Exchange where corporate regulation will be eased to maximise corporate profits. Under the proposed European Super Exchange (ESE) model, business practices shunned upon by national regulators are tipped to
Read More
According to the Australian Department of Health, half of us will experience some form of mental illness in our lifetime. Treatment is somewhat limited to prescription medications and psychotherapy. However, the current mental health crisis has seen researchers and practitioners alike wondering- is there a better way to approach these frighteningly common conditions? Enter psychedelics,
Read More
More than 230 million adults in China suffering from hypertension, a modifiable risk factor, will be able to reduce their risk of heart attack now that medtech company Uscom (ASX: UCM) has had the BP+ device approved for sale by Chinese regulators. Installed on the International Space Station, the BP+ is a patent-protected device that
Read More
